| Literature DB >> 26830336 |
Carl A Nosek1,2, W Chris Buck3,4, Alison C Caviness5, Abbie Foust6, Yewo Nyondo3, Madalitso Bottomani3, Peter N Kazembe3.
Abstract
BACKGROUND: The scale up of pediatric antiretroviral treatment programs across Sub-Saharan Africa over the last decade has brought increasing numbers of children into HIV care. This patient population requiring life-long care presents new challenges in the outpatient and inpatient settings. We sought to describe hospitalizations from a large pediatric HIV treatment facility to better understand the scope of the situation and identify areas for improved care delivery.Entities:
Mesh:
Year: 2016 PMID: 26830336 PMCID: PMC4736238 DOI: 10.1186/s12887-016-0556-3
Source DB: PubMed Journal: BMC Pediatr ISSN: 1471-2431 Impact factor: 2.125
Characteristics of 877 patients admitted to the Hospital, Malawi 2004–2010
| Number | Percent | |
|---|---|---|
| Sex | ||
| Female | 410 | 46.8 |
| Male | 467 | 53.2 |
| Number of Admissions | ||
| 1 | 685 | 78.1 |
| 2 | 152 | 17.3 |
| 3 | 21 | 2.4 |
| 4–8 | 19 | 2.2 |
| Patient Status as of October 2010 | ||
| Active | 393 | 44.8 |
| Died | 270 | 30.8 |
| Lost to follow-up | 95 | 10.8 |
| Transferred out | 119 | 13.6 |
| Age at First Admission | ||
| ≤ 11 months | 218 | 24.9 |
| 12–23 months | 229 | 26.1 |
| 24–35 months | 106 | 12.1 |
| 36–59 months | 101 | 11.5 |
| 60–119 months | 117 | 13.3 |
| 120–179 months | 78 | 8.9 |
| > 180 months | 28 | 3.2 |
| Time from Clinic Enrollment to First Admission | ||
| First Visit | 208 | 23.7 |
| 1–30 days | 157 | 17.9 |
| 31–90 days | 163 | 18.6 |
| 90–365 days | 207 | 23.6 |
| > 365 days | 142 | 16.2 |
Frequency of primary and overall diagnoses for 1137 admissions, Malawi 2004–2010
| Primary diagnosis N (%) | All diagnoses N (%) | |
|---|---|---|
| Malnutrition | 302 (26.6 %) | 401 (13.6 %) |
| Pneumonia | 212 (18.6 %) | 402 (13.6 %) |
| Malaria | 112 (9.9 %) | 233 (7.9 %) |
| Gastroenteritis | 68 (6.0 %) | 294 (10.0 %) |
| Sepsis | 68 (6.0 %) | 330 (11.2 %) |
| Other Infection | 53 (4.7 %) | 86 (2.9 %) |
| PCP Pneumonia | 48 (4.2 %) | 74 (2.5 %) |
| Tuberculosis | 45 (4.0 %) | 150 (5.1 %) |
| Kaposi Sarcoma | 43 (3.8 %) | 66 (2.2 %) |
| Anemia | 38 (3.3 %) | 174 (5.9 %) |
| Neurologic | 28 (2.5 %) | 78 (2.6 %) |
| Oncologic | 19 (1.7 %) | 21 (0.7 %) |
| Pulmonary (including LIP) | 16 (1.4 %) | 38 (1.3 %) |
| Medication Adverse Effect | 15 (1.3 %) | 18 (0.6 %) |
| Candidiasis | 8 (0.7 %) | 393 (13.3 %) |
| Hematologic | 5 (0.4 %) | 78 (2.6 %) |
| Cryptococcal Meningitis | 4 (0.4 %) | 5 (0.2 %) |
| Other | 36 (3.2 %) | 95 (3.2 %) |
| Unknown | 17 (1.5 %) | 17 (0.6 %) |
| TOTAL | 1137 (100 %) | 2951 (100 %) |
Fig. 1Stacked bar graph of primary admission diagnosis by age group, Malawi 2004–2010
Fig. 2Stacked bar graph of primary admission diagnosis by time from clinic enrollment, Malawi 2004–2010
Fig. 3Stacked bar graph of primary admission diagnosis by immune suppression, Malawi 2004–2010
Fig. 4Stacked bar graph of primary admission diagnosis by time on ART, Malawi 2004–2010